Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
Authors:
- Onur BaserOBOnur Baser
- Gabriela SamayoaGSGabriela Samayoa
- Nehir YaparNYNehir Yapar
- Erdem BaserEBErdem Baser
Open Access
- 25 September 2024
- journal article
- Published by The Journal of Health Economics and Outcomes Research in Journal of Health Economics and Outcomes Research
- Vol. 11 (2) , 86-94
Abstract
Background: Although increasing in prevalence, nonalcoholic steatohepatitis (NASH) is often undiagnosed in clinical practice. Objective: This study identified patients in the Veterans Affairs (VA) health system who likely had undiagnosed NASH using a machine learning algorithm. Methods: From a VA data set of 25 million adult enrollees, the study population was divided into NASH-positive, non-NASH, and at-risk cohorts. We performed a claims data analysis using a machine learning algorithm. To build our model, the study population was randomly divided into an 80% training subset and a 20% testing subset and tested and trained using a cross-validation technique. In addition to the baseline model, a gradient-boosted classification tree, naïve Bayes, and random forest model were created and compared using receiver operator characteristics, area under the curve, and accuracy. The best performing model was retrained on the full 80% training subset and applied to the 20% testing subset to calculate the performance metrics. Results: In total, 4 223 443 patients met the study inclusion criteria, of whom 4903 were positive for NASH and 35 528 were non-NASH patients. The remainder was in the at-risk patient cohort, of which 514 997 patients (12%) were identified as likely to have NASH. Age, obesity, and abnormal liver function tests were the top determinants in assigning NASH probability. Conclusions: Utilization of machine learning to predict NASH allows for wider recognition, timely intervention, and targeted treatments to improve or mitigate disease progression and could be used as an initial screening tool.Keywords
This publication has 35 references indexed in Scilit:
- The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based studyAnnals of Hepatology, 2022
- Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018The European Journal of Health Economics, 2021
- A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASHHepatology, 2021
- High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2020
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant CandidatesClinical Gastroenterology and Hepatology, 2019
- Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United StatesHepatology, 2019
- Big Data and Machine Learning in Health CareJAMA, 2018
- In search of new biomarkers for nonalcoholic fatty liver diseaseClinical Liver Disease, 2016
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy StudiesClinical Gastroenterology and Hepatology, 2015
- Naïve Bayes2011